Epi-daunomycin and epi-adriamycin compounds and method of use

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 4, 536 17, 536 18, 536122, A61K 3170, C07H 1524

Patent

active

041120760

ABSTRACT:
Disclosed is a process for preparing glycoside antitumor antibiotics, including the known compounds daunomycin, adriamycin, 4'-epi-daunomycin and 4'-epi-adriamycin and the novel antibiotics, 3',4'-epi-6'-hydroxydaunomycin, 3',4'-epi-6'-hydroxyadriamycin. 3',4'-epi-daunomycin, 3',4'-epi-adriamycin, 4-demethoxy-4'-epi-daunomycin and 4-demethoxy-4'-epi-adriamycin. Process involves reacting daunomycinone or 4-demethoxy-daunomycinone with a protected 1-halo derivative of 3,4-epi-6-hydroxydaunosamine, 3,4-epi-daunosamine or 4-epi-daunosamine in an inert solvent in the presence of a soluble silver salt catalyst to form a protected derivative of the glycoside antibiotic and removing the protecting groups.

REFERENCES:
patent: 3803124 (1974-04-01), Arcamone et al.
patent: 4025623 (1977-05-01), Arcamone et al.
patent: 4046878 (1977-09-01), Patelli et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Epi-daunomycin and epi-adriamycin compounds and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Epi-daunomycin and epi-adriamycin compounds and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epi-daunomycin and epi-adriamycin compounds and method of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2096620

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.